Profile data is unavailable for this security.
About the company
Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The Company is commercializing sugarBEAT and proBEAT. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and also be used to screen pre-diabetic patients. The sugarBEAT device extracts from analytes, such as glucose, from the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor. The proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service.
- Revenue in USD (TTM)0.00
- Net income in USD-10.65m
- Incorporated2013
- Employees36.00
- LocationNemaura Medical Inc57 W 57th StNEW YORK 10019-2802United StatesUSA
- Phone+44 (150) 922-2912
- Websitehttps://nemauramedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LogicMark Inc | 9.74m | -15.46m | 369.81k | 26.00 | -- | 0.0231 | -- | 0.038 | -8.62 | -8.62 | 5.21 | 5.37 | 0.4993 | 3.87 | 687.63 | 374,625.80 | -72.96 | -28.39 | -78.79 | -33.18 | 66.93 | 67.24 | -146.12 | -63.55 | 2.36 | -- | 0.00 | -- | -16.67 | -10.32 | -117.56 | -- | 37.76 | -- |
BIOLASE Inc | 46.10m | -36.19m | 391.59k | 157.00 | -- | -- | -- | 0.0085 | -11.65 | -11.65 | 3.32 | -0.0636 | 1.31 | 2.55 | 8.73 | 293,611.50 | -54.64 | -49.28 | -185.36 | -85.80 | 33.01 | 35.27 | -41.65 | -50.72 | 0.3589 | -6.00 | 1.19 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
SETO Holdings Inc | 4.96m | -652.00k | 592.00k | 18.00 | -- | 0.0537 | -- | 0.1194 | -0.056 | -0.056 | 0.3994 | 0.134 | 1.57 | 2.65 | 8.51 | -- | -20.70 | 3.84 | -29.07 | 5.95 | 52.83 | 52.44 | -13.15 | 3.92 | 0.9921 | 1.24 | 0.304 | 0.00 | 19.01 | 5.44 | -61.23 | -- | -- | -- |
Nemaura Medical Inc | 0.00 | -10.65m | 714.23k | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
InnerScope Hearing Technologies, Inc. | 334.45k | -7.15m | 739.29k | 24.00 | -- | -- | -- | 2.21 | -38.18 | -38.18 | 0.428 | -6.96 | 0.0955 | 3.93 | 1.71 | -- | -204.11 | -27.82 | -- | -94.53 | 17.79 | 58.17 | -2,138.50 | -42.13 | 0.0022 | -0.4232 | -- | -- | -- | 100.59 | -- | -- | 233.50 | -- |
Dynatronics Corp | 32.53m | -3.43m | 743.34k | 111.00 | -- | 0.1083 | -- | 0.0229 | -0.7237 | -0.7237 | 6.86 | 2.67 | 1.16 | 3.83 | 9.08 | 293,098.80 | -9.63 | -7.48 | -13.37 | -10.07 | 23.47 | 25.81 | -8.29 | -5.98 | 0.6442 | -5.44 | 0.2139 | -- | -19.89 | -12.26 | 39.47 | -- | 1.66 | -- |
Catheter Precision Inc | 436.00k | -9.49m | 912.75k | 14.00 | -- | 0.0172 | -- | 2.09 | -12.95 | -12.95 | 0.6046 | 18.90 | 0.0141 | 0.5574 | 3.89 | 31,142.86 | -30.71 | -- | -33.63 | -- | 92.20 | -- | -2,176.84 | -- | 0.098 | -- | 0.0434 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
Nano Mobile Healthcare Inc | 0.00 | -5.46m | 982.13k | 3.00 | -- | -- | -- | -- | -0.2255 | -0.2255 | 0.00 | -0.0129 | 0.00 | -- | -- | 0.00 | -10,475.82 | -- | -- | -- | -- | -- | -- | -- | -- | -0.3173 | -- | -- | -- | -- | -- | -- | -- | -- |
Remedent Inc | 1.13m | -259.38k | 999.80k | 16.00 | -- | 0.2112 | -- | 0.8857 | -0.013 | -0.013 | 0.0565 | 0.2367 | 0.1474 | 3.45 | 2.69 | -- | -3.24 | 7.35 | -5.20 | 12.93 | 65.38 | 64.60 | -21.97 | 21.20 | 0.2033 | -0.772 | 0.00 | -- | -33.63 | -21.70 | -140.31 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Alyeska Investment Group LPas of 09 May 2024 | 845.00k | 2.09% |
XTX Markets LLCas of 31 Mar 2024 | 18.87k | 0.05% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 2.01k | 0.01% |
Desjardins Securities, Inc.as of 31 Mar 2024 | 1.95k | 0.01% |
UBS Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Citadel Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Tower Research Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Wells Fargo Advisors Financial Network LLCas of 31 Mar 2024 | 0.00 | 0.00% |
Two Sigma Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |
RBC Dominion Securities, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |